We came across a bullish thesis on Sana Biotechnology, Inc. on Stock Invader’s Substack. In this article, we will summarize the bulls’ thesis on SANA. Sana Biotechnology, Inc.’s share was trading at $4.00 as of February 9th.
Elena Pavlovich/Shutterstock.com
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. SANA has emerged as a compelling player in the race to cure type 1 diabetes (T1D) with its...
